GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of glycaemic control threads, summarised so you do not have to read them — 26 comments in the full submission. View in context.
319
c/t2dglp1·submitted 5 months ago by u/gentle_correction

three years of glycaemic control threads, summarised so you do not have to read them

Questionbranch of 5 comments

Confession thread, sort of. I went from 1.7mg to 0.25mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 7 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have early…

Read the full submission and all 26 comments →

This branch

5 comments, started 5 months ago
u/gentle_correctionMOD43 points·5 months ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/throwaway_918212 points·5 months ago

Yeah, glycaemic control is the original use.

replysharereportpermalink
[removed]5 points·5 months ago

[removed by moderator]

replysharereportpermalink
u/gentle_correctionOPnice about it2 points·5 months ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/fabio_lehtinen1 point·5 months ago

insulin and sulfonylurea interactions are real hypo risk

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/t2dglp1
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/a1c_arcu/fasting_insulin_fu/gentle_correction
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →